Hadassah Is First in Mideast to Use New Tumor Diagnostic Test
The Hadassah Medical Center’s Molecular Pathology and Diagnostic Tumors Department is the first in the Middle East – and just the third outside of the United States – to conduct the new tumor diagnostic test FoundationOne-CDx (F1CDx) within its own laboratories. F1CDx detects and identifies genetic changes in cancerous tumors….
